% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Fu:277796,
author = {Y.-C. Fu and S.-B. Liang and W.-J. Huang and L.-S. Chen and
D.-M. Chen$^*$ and L.-Z. Liu and M. Luo and X.-F. Zhong and
X.-Y. Xu},
title = {{P}rognostic {V}alue of {L}ymph {N}ode {N}ecrosis at
{D}ifferent {N} {S}tages in {P}atients with {N}asopharyngeal
{C}arcinoma.},
journal = {Journal of cancer},
volume = {14},
number = {11},
issn = {1837-9664},
address = {Wyoming, NSW},
publisher = {Ivyspring Internat. Publ.},
reportid = {DKFZ-2023-01507},
pages = {2085 - 2092},
year = {2023},
abstract = {Background: Lymph node necrosis (LNN), including
retropharyngeal nodal necrosis and cervical nodal necrosis,
which is related to radiotherapy/ chemotherapy resistance,
is a common phenomenon in nasopharyngeal carcinoma (NPC).
This study was to assess the prognostic value of LNN at
different N stages in NPC patients. Materials and Methods:
In total, 1,665 newly diagnosed NPC patients at stage
TxN1-3M0 from two centers were enrolled. Univariate and
multivariate models were constructed to assess the
association between LNN and long-term survival outcomes. The
propensity score matching method was performed to balance
treatment groups for baseline characteristics. Results: Of
the 1,665, 540 patients (540/1665, $32.4\%)$ were diagnosed
with LNN, of which $54.1\%$ (292/540) patients were at stage
N1, $31.3\%$ (169/540) at stage N2, and $14.6\%$ (79/540) at
stage N3. Univariate and multivariate analyses indicated LNN
as an independent predictor for progression‑free survival
(PFS), overall survival (OS), distant metastasis-free
survival (DMFS), and locoregional relapse-free survival
(LRRFS) in stage N1-3 patients (all P<0.001). When patients
were analyzed according to stage, similar findings were
observed for N1 patients (all P<0.001); for N2 patients, LNN
independently predicted PFS (P=0.003), OS (P=0.011), and
DMFS (P=0.004), and for stage N3, LNN only independently
predicted LRRFS (P=0.019). 123 pairs of patients who
received induction chemotherapy plus concurrent
chemoradiotherapy or only concurrent chemoradiotherapy were
matched, adding induction chemotherapy improved 5-year OS,
PFS and LRFFS, but the results were not statistically
significant. Conclusions: In NPC patients, LNN could
independently predict poor prognosis at all N1-3 stages and
at each N stage (N1 to N3). The value of adding induction
chemotherapy to concurrent chemoradiotherapy in patients
with LNN still requires further prospective studies.},
keywords = {induction chemotherapy (Other) / lymph node necrosis
(Other) / nasopharyngeal carcinoma (Other) / prognosis
(Other) / stage N1-3 (Other)},
cin = {E055},
ddc = {610},
cid = {I:(DE-He78)E055-20160331},
pnm = {315 - Bildgebung und Radioonkologie (POF4-315)},
pid = {G:(DE-HGF)POF4-315},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:37497418},
pmc = {pmc:PMC10367925},
doi = {10.7150/jca.84854},
url = {https://inrepo02.dkfz.de/record/277796},
}